This action helps reach optimal results with careful monitoring
The FDA last week issued warning letters against a handful of companies flagging violations regarding the promotion and sale of unapproved weight-loss drugs, including unlicensed versions of the blockbuster therapies semaglutide and tirzepatide
After being stimulated by GLP-1 or various agonists, GLP-1R in pancreatic cells internalizes and is eventually recycled back to the cell surface
In head-to-head clinical trials (like the SURPASS studies), Tirzepatide has consistently outperformed Semaglutide in terms of total weight loss and blood sugar reduction
It lowers blood sugar by improving insulin sensitivity, decreasing the amount of blood sugar the liver produces, and reducing the amount of sugar the digestive system absorbs
It describes lipohypertrophy as a buildup of fatty tissue at repeatedly used injection sites that can impair medication absorption and cause discomfort